|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-04
|
$1,917,582
|
$479,396
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
The role of macroH2A variants in cancer and senescence
|
1R01CA155232-01A1
|
$346,179
|
$346,179
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$112,723
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$7,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$7,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$2,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$4,070
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
5R01CA133010-04
|
$395,050
|
$197,525
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Skp2 in androgen-dependent proliferation of prostate cancer cells
|
5R01CA127901-04
|
$300,705
|
$60,141
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$404,941
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$20,674
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$1,549,807
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
|
1R01CA162393-01A1
|
$639,914
|
$639,914
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Geospatial Factors and Impacts II
|
2R01CA126858-05
|
$403,837
|
$403,837
|
MOBLEY, LEE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$19,447
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Advanced glycation end products and colorectal cancer risk in women
|
5R03CA156626-02
|
$80,193
|
$40,097
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
DNA Repair and Replication Re-start in vivo
|
5R01CA085777-09
|
$291,579
|
$14,579
|
Rosenberg, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanism and Consequences of Telomere Dysfunction
|
5R01CA133249-05
|
$308,957
|
$77,239
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integrative Metabolomics of Prostate Cancer Progression
|
5R01CA133458-05
|
$314,511
|
$78,628
|
Sreekumar, Arun
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Age in Liver Cancer
|
5R01CA159942-02
|
$324,738
|
$324,738
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Characterization of prostatic stem cells and prostate cancer-initiating cells
|
3R00CA125937-05S2
|
$56,448
|
$14,112
|
Xin, Li
|
BAYLOR COLLEGE OF MEDICINE
|
|
Spindle Assembly Checkpoint, Chromosome Stability, and Cancer
|
2R01CA122623-05
|
$314,977
|
$157,489
|
ZHANG, PUMIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Function of Cdc14B in DNA Damage Repair and Tumorigenesis
|
5R01CA116097-07
|
$269,732
|
$67,433
|
ZHANG, PUMIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$24,320
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$3,816
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-04
|
$688,070
|
$172,018
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
PTEN and ontogenesis and tumor suppression
|
5R01CA082328-15
|
$340,612
|
$22,140
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S1
|
$300,000
|
$12,000
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S2
|
$139,989
|
$5,600
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
5U10CA139519-03
|
$310,336
|
$12,413
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-22
|
$328,240
|
$164,120
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-19
|
$1,716,455
|
$858,228
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Heat shock proteins in signaling and cancer
|
5R01CA081244-14
|
$344,929
|
$344,929
|
SHERMAN, MICHAEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$3,427
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$16,236
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$232,789
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$91,448
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-21
|
$1,813,397
|
$1,178,708
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary Methyl Score, Genomic DNA Methylation and Colorectal Cancer
|
5R01CA136950-04
|
$323,349
|
$161,675
|
CHO, EUNYOUNG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathoepidemiology of Endometrial Cancer Risk
|
2R01CA082838-10A1
|
$359,654
|
$35,965
|
devivo, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multidisciplinary Training in Image-Guided Therapy
|
5R25CA089017-10
|
$539,399
|
$53,940
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-04S1
|
$167,479
|
$167,479
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-04
|
$1,548,411
|
$1,548,411
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression
|
5R01CA136578-04
|
$337,130
|
$84,283
|
Mucci, Lorelei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The effects of randomized, low-dose hormone therapy on mammographic density in KE
|
5R01CA136918-03
|
$325,509
|
$325,509
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-13
|
$4,908,989
|
$49,090
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Whole Genome Association Study of Mammographic Density
|
5R01CA131332-04
|
$373,231
|
$186,616
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Aging for this search: $86,910,095
|